文献速递其他结缔组织病

放射治疗对系统性硬化症合并乳腺癌患者硬皮病及癌症结局的影响

Impact of Radiation Therapy on Scleroderma and Cancer Outcomes in Scleroderma Patients With Breast Cancer.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-01-01

从约翰斯·霍普金斯大学与匹兹堡大学硬皮病中心数据库中纳入系统性硬化症(SSc)合并乳腺癌患者,比较接受与未接受乳腺放射治疗者在放疗野皮肤反应及12、24个月时mRSS与FVC%的变化。结果显示放疗野皮肤增厚约见于50%患者,未见肺部或全身皮肤疾病活动证据;有限样本中两组mRSS与FVC%无显著变化。作者认为对乳腺癌使用放射治疗可视为基于知情患者偏好的选择。

要点

  • 放疗野皮肤增厚见于约翰斯·霍普金斯48.4%、匹兹堡54.6%的可评估患者。
  • 红斑、水疱、溃疡在两家中心的发生比例不一,溃疡仅见于约翰斯·霍普金斯1例。
  • 有限样本中接受与未接受放疗者的mRSS与FVC%无显著变化。

核心结论

  • 这些数据提示,SSc合并乳腺癌患者并非必然发生导致局部组织纤维化的放疗损伤,约50%患者出现该情况,且无肺部或全身皮肤疾病活动证据。
  • 作者认为,基于知情患者的偏好,乳腺癌的放射治疗可视为一种选择。

研究设计与样本

  • 从约翰斯·霍普金斯大学与匹兹堡大学硬皮病中心数据库中识别SSc合并乳腺癌患者。
  • 约翰斯·霍普金斯116例乳腺癌患者中43例、匹兹堡37例中26例接受了乳腺放射治疗。
  • 比较接受与未接受放射治疗者在癌症诊断后12个月和24个月时mRSS与FVC%的变化,并观察放疗野内红斑、水疱、溃疡或皮肤增厚。

主要发现

  • 约翰斯·霍普金斯有数据者中,30例中4例(13.3%)出现红斑,30例中无1例出现水疱,30例中1例(3.3%)出现溃疡,31例中15例(48.4%)放疗野皮肤增厚。
  • 匹兹堡有数据者中,11例中7例(63.6%)出现红斑,11例中2例(18.2%)出现水疱,11例中无1例出现溃疡,11例中6例(54.6%)放疗野皮肤增厚。
  • 在有限样本中,接受与未接受放射治疗者的mRSS或FVC%无显著变化。

关键数值与推荐

  • 约翰斯·霍普金斯放疗野红斑4/30(13.3%)、水疱0/30、溃疡1/30(3.3%)、皮肤增厚15/31(48.4%)。
  • 匹兹堡放疗野红斑7/11(63.6%)、水疱2/11(18.2%)、溃疡0/11、皮肤增厚6/11(54.6%)。
  • 接受与未接受放射治疗者癌症诊断后12个月和24个月mRSS与FVC%无显著变化。

临床怎么用

  • 作者认为,基于知情患者的偏好,乳腺癌的放射治疗可视为一种选择。

局限性

  • 原文在mRSS与FVC%比较处写明为有限样本(in a limited sample)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We examined systemic sclerosis (SSc) patients with breast cancer to identify the prevalence of radiation complications and to examine outcomes in SSc patients who received radiation therapy as part of their cancer treatment. METHODS: Patients with SSc and breast cancer were identified from the Johns Hopkins and University of Pittsburgh Scleroderma Center databases. We examined whether erythema, blistering, ulceration, or thickening of the skin developed in the radiation therapy port. Changes in modified Rodnan skin thickness score (mRSS) and forced vital capacity percent predicted (FVC%) at 12 and 24 months post-cancer diagnosis were compared between patients who did and those who did not receive radiation therapy. RESULTS: A total of 43 of 116 breast cancer patients at Johns Hopkins and 26 of 37 patients at the University of Pittsburgh received breast radiation therapy. At Johns Hopkins, 4 of 30 (13.3%) patients with available data developed erythema, none had blistering, 1 of 30 (3.3%) developed ulceration, and 15 of 31 (48.4%) had skin thickening in the radiation port. At the University of Pittsburgh, 7 of 11 patients (63.6%) with available data developed erythema, 2 of 11 (18.2%) had blistering, none developed ulceration, and 6 of 11 (54.6%) had skin thickening in the radiation port. In a limited sample, there were no significant changes in the mRSS or FVC% between patients who did and those who did not receive radiation therapy. CONCLUSION: These data suggest that radiation injury causing local tissue fibrosis is not inevitable in SSc patients with breast cancer, occurring in approximately 50% of patients without evidence of lung or generalized skin disease flare. Therefore, the use of radiation therapy for breast cancer is considered an option based on the informed patient's preference.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Shah DJ, Hirpara R, Poelman CL, et al. Impact of Radiation Therapy on Scleroderma and Cancer Outcomes in Scleroderma Patients With Breast Cancer. Arthritis Care Res (Hoboken). 2018. PMID: 29316366. doi:10.1002/acr.23505

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。